PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
Metabolon Expands Microbiome Panel to Strengthen Industry Leadership in Functional Microbiome Research
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Bambusa Therapeutics Appoints Howard Liang, Ph.D. to its Board of Directors and Establishes Scientific Advisory Board
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Ractigen Therapeutics Announces Landmark Publication in Nature Medicine Highlighting Unprecedented Preclinical Efficacy and Positive First-in-Human Clinical Data for RAG-17 in SOD1-ALS
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Asthma
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Ascletis Selects for Clinical Development a Fixed-Dose Combination of First-in-Class Oral Small Molecule GIPR Agonist, ASC48, and Oral Small Molecule GLP-1R Agonist, ASC30
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Kelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Asthma
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
World-renowned bioelectronics pioneer Prof. John Rogers to present second PAIR--Cambridge NeuroWorks online neuroscience seminar
2026-07-15T    Biotechnology   Computer/Electronics   Education   Higher Education 
GEM and Senhwa Biosciences have formally executed a Share Purchase Agreement for up to NT$500 million
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved